Loading
Latest filing published 01 Jun 2022 for Genocea Biosciences, INC., €1,243. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by George Siber is known so far (1 June 2022): an open-market sale, €1,243, in Genocea Biosciences, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration